Sigachi Industries gets ToR approval for API and specialty chemicals manufacturing facility in Andhra Pradesh
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
This strategic expansion marks a significant step in the company's global growth strategy
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
The initiative was announced at World Hypertension Congress, Chennai
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
For FY25, Revenue from operation grew 28.8 per cent YoY to Rs. 70.1 crore
Subscribe To Our Newsletter & Stay Updated